TriVista Identifies $2.3M EBITDA Savings and $1.8M Cash Savings for Medical Device Company - TriVista

We value your privacy

We use cookies to enhance your browsing experience, serve personalised ads or content, and analyse our traffic. By clicking "Accept All", you consent to our use of cookies.

Customise Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorised as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyse the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customised advertisements based on the pages you visited previously and to analyse the effectiveness of the ad campaigns.

No cookies to display.

TriVista > About Us > Case Studies
Case Study

TriVista Identifies $2.3M EBITDA Savings and $1.8M Cash Savings for Medical Device Company

Services Provided
Operations Due Diligence
Industries Served
Medical, Healthcare, and Pharmaceuticals

The Challenge

A private equity firm looking to acquire a $15M revenue medical device company retained TriVista to perform operations due diligence.

Our Approach

  • Conducted site visits at three locations across America
  • Interviewed management teams at each location
  • Assessed site engineering and manufacturing capabilities during facility walk-throughs and operational analysis
  • Reviewed detailed new product development and production ramping plans for over 20 new medical components and devices

The Results

  • Identified over $2.3M EBITDA savings opportunities through productivity improvements, rework reduction, scrap reduction and strategic purchasing opportunities
  • Also identified $1.8M cash savings were identified by driving improved inventory turns through implementation of Vendor Managed Inventory (VMI) and strategic supplier relations

To find out how TriVista can help you achieve similar outcomes, contact us today:

"*" indicates required fields

This field is for validation purposes and should be left unchanged.